Email updates

Keep up to date with the latest news and content from Molecular Pain and BioMed Central.

Open Access Highly Accessed Research

Transient receptor potential melastatin 8 (TRPM8) channels are involved in body temperature regulation

Narender R Gavva1*, Carl Davis2, Sonya G Lehto1, Sara Rao1, Weiya Wang1 and Dawn XD Zhu1

Author Affiliations

1 Department of Neuroscience, Amgen, One Amgen Center Drive, Thousand Oaks, CA, 91320, USA

2 Department of Pharmacokinetics and Drug Metabolism, Amgen Inc, Thousand Oaks, CA, 91320-1799, USA

For all author emails, please log on.

Molecular Pain 2012, 8:36  doi:10.1186/1744-8069-8-36

Published: 9 May 2012

Abstract

Background

Transient receptor potential cation channel subfamily M member 8 (TRPM8) is activated by cold temperature in vitro and has been demonstrated to act as a ‘cold temperature sensor’ in vivo. Although it is known that agonists of this ‘cold temperature sensor’, such as menthol and icilin, cause a transient increase in body temperature (Tb), it is not known if TRPM8 plays a role in Tb regulation. Since TRPM8 has been considered as a potential target for chronic pain therapeutics, we have investigated the role of TRPM8 in Tb regulation.

Results

We characterized five chemically distinct compounds (AMG0635, AMG2850, AMG8788, AMG9678, and Compound 496) as potent and selective antagonists of TRPM8 and tested their effects on Tb in rats and mice implanted with radiotelemetry probes. All five antagonists used in the study caused a transient decrease in Tb (maximum decrease of 0.98°C). Since thermoregulation is a homeostatic process that maintains Tb about 37°C, we further evaluated whether repeated administration of an antagonist attenuated the decrease in Tb. Indeed, repeated daily administration of AMG9678 for four consecutive days showed a reduction in the magnitude of the Tb decrease Day 2 onwards.

Conclusions

The data reported here demonstrate that TRPM8 channels play a role in Tb regulation. Further, a reduction of magnitude in Tb decrease after repeated dosing of an antagonist suggests that TRPM8’s role in Tb maintenance may not pose an issue for developing TRPM8 antagonists as therapeutics.

Keywords:
TRPM8 antagonist; AMG0635; AMG2850; AMG8788; AMG9678; Compound 496; Body temperature regulation